Our corporate investigations coverage identifies companies and industries that may be impacted by new or existing laws and regulations. For individual companies, we report on specific business practices that may pose legal or regulatory risks. Our industry-focused content examines new regulations that may materially affect an entire industry, as well as identifying the companies within the industry likely to be most impacted. Our journalists understand the impact regulatory agency actions can have on financial markets and provide insights on the potential results of regulatory actions, whether they include fines or material changes to a company’s business or an industry’s operation.
PDF
CONTACT US
Super.com’s cash advance offering, “Super.com Cash,” resembles Earned Wage Access (EWA) products that have faced private litigation and federal enforcement, as well as scrutiny from California’s Department of Financial Protection and Innovation (DFPI) for allegedly failing to...
Adverse-event reports for Insulet Corporation’s (PODD) Omnipod 5 insulin pump that describe the specific defect behind two recalls earlier this spring reached an all-time monthly high in July, according to a Capitol Forum analysis of the FDA’s Manufacturer and User Facility Device...
The information contained in this report is compiled from the FDA’s Manufacturer and User Facility Device Experience (MAUDE) database. The MAUDE database contains reports of deaths, injuries, and malfunctions relating to the use of medical devices and is updated monthly with reports...
On July 23 and 24, an advisory committee voted to recommend that the Food and Drug Administration allow compounding pharmacies to work with six non-FDA-approved peptides— protein building blocks that proponents such as Health and Human Services Secretary Robert F. Kennedy Junior praise...
This month, hundreds of data brokers must begin deleting the personal information of more than 470,000 residents who registered with California’s Delete Request and Opt-Out Platform (DROP)—a first-of-its-kind online tool that could impose unprecedented fines on noncompliant companies...
Concerns about the life insurance and annuity industry have focused largely on the riskiness of insurers’ investments as they’ve moved policyholder money into private, illiquid...
As the Trump Administration continues its crackdown on hospice fraud, a Capitol Forum investigation has found that VITAS Healthcare, a subsidiary of Chemed (CHE) and the largest hospice operator in the country, may be systematically overbilling Medicare by tens of millions of dollars...
Four sources with direct knowledge of the daily operations at the logistics startup SpeedX raised concerns with The Capitol Forum about long hours, a lack of overtime pay, unsafe conditions, and injuries among warehouse...
Financial services and travel booking company Super.com may be engaging in deceptive billing and subscription tactics, according to widespread consumer complaints. The alleged practices, which resemble allegations in the federal government’s lawsuit against Uber (UBER) for its Uber One...
The Capitol Forum’s corporate investigations team has demonstrated a consistent track record of successfully identifying companies that have legal, regulatory, or business risk.
DOWNLOAD PDF
Partner and Antitrust Chair, Fried Frank
"The Capitol Forum’s articles include a good mix of investigative journalism combined with expert analysis and opinion."
Founding Partner, Geradin Partners; Professor of Competition Law and Economics, Tilburg University
“The Capitol Forum’s European coverage stands out for its depth, accuracy, and timeliness. Their investigative reporting and analysis on antitrust, corporate conduct, and regulatory developments offer valuable insights for practitioners and academics alike. As someone deeply engaged in European competition law, I’ve found their work to be consistently thoughtful and impactful.”
Partner, Willkie Farr & Gallagher
"Capitol Forum’s comprehensive and diligent reporting on key competitive issues provides helpful insights on and contributes to the vigorous debate around antitrust policy and enforcement."
Partner, Fenwick & West
"I rely on Capitol Forum daily for its valuable combination of timely information and unique insights on key deals and cases. It offers viewpoints and analyses that others don’t, which has become particularly valuable in the current policy environment."
